Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence

Steven Shoptaw, Alice Huber, James Peck, Xiaowei Yang, Juanmei Liu, Dang Jeff Dang, John Roll, Benjamin Shapiro, Erin Rotheram-Fuller, Walter Ling

Research output: Contribution to journalArticle

94 Scopus citations

Abstract

Background: Methamphetamine dependence and associated medical and psychiatric concerns are significant public health issues. This project evaluated the efficacy of sertraline (50 mg bid) and contingency management (CM) for the treatment of methamphetamine dependence. Method: In this randomized, placebo-controlled, double-blind trial, participants completed a 2-week non-medication baseline and were randomized to one of four conditions for 12 weeks: sertraline plus CM (n = 61), sertraline-only (n = 59), matching placebo plus CM (n = 54), or matching placebo-only (n = 55). All participants attended clinic thrice-weekly for data collection, medication dispensing, and relapse prevention groups. Outcomes included methamphetamine use (urine drug screening and self-reported days of use), retention (length of stay), drug craving (visual analogue scale), and mood symptoms (Beck Depression Inventory). Results: No statistically significant main or interaction effects for sertraline or CM in reducing methamphetamine use were observed using a generalized estimating equation (GEE), although post hoc analyses showed the sertraline-only condition had significantly poorer retention than other conditions (χ2 (3) = 8.40, p < 0.05). Sertraline conditions produced significantly more adverse events than placebo conditions. A significantly higher proportion of participants in CM conditions achieved three consecutive weeks of methamphetamine abstinence than those in non-CM conditions. Conclusions: These data do not demonstrate improved outcomes for sertraline versus placebo for treatment of methamphetamine dependence; indeed, they suggest sertraline is contraindicated for methamphetamine dependence. Findings provide support for the use of contingency management for treatment of methamphetamine dependence.

Original languageEnglish (US)
Pages (from-to)12-18
Number of pages7
JournalDrug and Alcohol Dependence
Volume85
Issue number1
DOIs
StatePublished - Oct 15 2006

Keywords

  • Contingency management
  • Drug abuse
  • Medications
  • Methamphetamine
  • Sertraline

ASJC Scopus subject areas

  • Medicine(all)
  • Behavioral Neuroscience
  • Toxicology
  • Health(social science)

Fingerprint Dive into the research topics of 'Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence'. Together they form a unique fingerprint.

  • Cite this

    Shoptaw, S., Huber, A., Peck, J., Yang, X., Liu, J., Jeff Dang, D., Roll, J., Shapiro, B., Rotheram-Fuller, E., & Ling, W. (2006). Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug and Alcohol Dependence, 85(1), 12-18. https://doi.org/10.1016/j.drugalcdep.2006.03.005